-
Osimertinib dimesylate
- names:
Osimertinib dimesylate
- CAS号:
2070014-82-1
MDL Number: - MF(分子式): C30H41N7O8S2 MW(分子量): 691.82
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|
| 中文别名 | |
| 英文别名 | Osimertinib dimesylate |
| CAS号 | 2070014-82-1 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C30H41N7O8S2 |
| 分子量 Molecular Weight | 691.82 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度0.4 mg/mL(0.58 mM;Need ultrasonic and warming) |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
| 产品说明 | |
| Introduction | Osimertinib dimesylate (AZD-9291 dimesylate) is an irreversible and mutant selectiveEGFRinhibitor withIC50s of 12 and 1 nM against EGFRL858Rand EGFRL858R/T790M, respectively. |
| Application1 | |
| Application2 | |
| Application3 |
Osimertinib dimesylate (AZD-9291 dimesylate) 为不可逆的突变体选择性EGFR抑制剂;对EGFRL858R和EGFRL858R/T790M的IC50值分别为12 和 1 nM。Osimertinib dimesylate (AZD-9291 dimesylate) is an irreversible and mutant selectiveEGFRinhibitor withIC50s of 12 and 1 nM against EGFRL858Rand EGFRL858R/T790M, respectively.
| 【1】.Cross DA, et al. AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. Cancer Discov. 2014 Sep;4(9):1046-61. |
| 【2】.Finlay MR, et al. Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistancemutations that spares the wild type form of the receptor. J Med Chem. 2014 Oct 23;57(20):8249-67. |
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


